These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34757546)

  • 1. Metal ion chelation enhances tissue plasminogen activator (tPA)-induced thrombolysis: an in vitro and in vivo study.
    Yu X; Wang Z; Li YV
    J Thromb Thrombolysis; 2022 Feb; 53(2):291-301. PubMed ID: 34757546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico study of combination thrombolytic therapy with alteplase and mutant pro-urokinase for fibrinolysis in ischemic stroke.
    Yang Y; Gu B; Xu XY
    Comput Biol Med; 2024 Mar; 171():108141. PubMed ID: 38367449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Chinese herbal medicine for tPA thrombolysis in experimental stroke: A systematic review and meta-analysis.
    Ye Y; Zhu YT; Xin XY; Zhang JC; Zhang HL; Li D
    Phytomedicine; 2022 Jun; 100():154072. PubMed ID: 35349833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
    Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
    Liu S; Feng X; Jin R; Li G
    Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
    Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
    Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
    Ma H; Jiang Z; Xu J; Liu J; Guo ZN
    Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc chelation promotes streptokinase-induced thrombolysis
    Wang Z; Yu X; Li YV
    Int J Physiol Pathophysiol Pharmacol; 2017; 9(5):137-146. PubMed ID: 29209450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
    Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin.
    Goncalves A; Su EJ; Muthusamy A; Zeitelhofer M; Torrente D; Nilsson I; Protzmann J; Fredriksson L; Eriksson U; Antonetti DA; Lawrence DA
    Blood; 2022 Jul; 140(4):388-400. PubMed ID: 35576527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
    Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
    Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; del Zoppo G; Yamaguchi T
    Cochrane Database Syst Rev; 2000; (2):CD000213. PubMed ID: 10796329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.
    Roncal C; Martinez de Lizarrondo S; Salicio A; Chevilley A; Rodriguez JA; Rosell A; Couraud PO; Weksler B; Montaner J; Vivien D; Páramo JA; Orbe J
    Cardiovasc Res; 2017 Aug; 113(10):1219-1229. PubMed ID: 28379489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
    Molina CA; Ribo M; Rubiera M; Montaner J; Santamarina E; Delgado-Mederos R; Arenillas JF; Huertas R; Purroy F; Delgado P; Alvarez-Sabín J
    Stroke; 2006 Feb; 37(2):425-9. PubMed ID: 16373632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
    van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
    Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Intracranial Hemorrhage Following Intravenous tPA (Tissue-Type Plasminogen Activator) for Acute Stroke Is Low in Children.
    Amlie-Lefond C; Shaw DWW; Cooper A; Wainwright MS; Kirton A; Felling RJ; Abraham MG; Mackay MT; Dowling MM; Torres M; Rivkin MJ; Grabowski EF; Lee S; Kurz JE; McMillan HJ; Barry D; Lee-Eng J; Ichord RN
    Stroke; 2020 Feb; 51(2):542-548. PubMed ID: 31842706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Enhancing Effect of Focused Ultrasound on TNK-Tissue Plasminogen Activator-Induced Thrombolysis Using an In Vitro Circulating Flow Model.
    Papadopoulos N; Yiallouras C; Damianou C
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2891-2899. PubMed ID: 27599905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.
    Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y
    J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.